Approximately 3,474 Shares Of Aehr Test Systems (AEHR) Were Sold By This Insider.


Aehr Test Systems (NASDAQ:AEHR) finished Wednesday with a subtraction of -$0.32 to close at $19.90, a downside of -1.58 percent. An average of 1,142,280 shares of common stock have been traded in the last five days. There was a fall of -$2.60 in the past week, and it reached a new high 9 times over the past 12 months. The last 20 days have seen an average of 1,194,435 shares traded, while the 50-day average volume stands at 1,551,642.

AEHR stock has decreased by -23.08% in the last month. The company shares reached their 1-month lowest point of $19.54 on 12/28/22. With the stock rallying to its 52-week high on 12/01/22, shares of the company touched a low of $6.71 and a high of $28.00 in 52 weeks. It has reached a new high 6 times so far this year and lost -17.70% or -$4.28 in price. In spite of this, the price is down -28.93% from the 52-week high.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Insider Transactions

AEHR stock investors should be aware that Aehr Test Systems (AEHR) stock had its last reported insider trading activity 28 days ago on Dec 01. In this transaction, the insider spent $93,832. Director, OLIPHANT LAURA, disposed of 1,901 shares at a price of $27.00 on Nov 23. The insider now owns more than $51,327 worth of shares. Prior to that, President and CEO Erickson Gayn went on to Sale 69,690 shares at $25.90 each on Nov 15. An amount of $1,804,769 was transacted.

Valuation Metrics

Aehr Test Systems (AEHR) has a trailing price-to-earnings (P/E) ratio of 61.04. The stock’s beta is 1.79. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 9.73, the price-to-book (PB) ratio at 10.53, and the price-to-cash flow ratio at 115.76.

Financial Health

The quick ratio of Aehr Test Systems for the three months ended August 30 was 4.30, and the current ratio was 6.00, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending August 30. Its gross profit as reported stood at $23.66 million compared to revenue of $50.83 million.

Earnings Surprise

In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $0.59 million in the quarter, while revenues of $5.79 million were shrunk -18.64%. The analyst consensus anticipated Aehr Test Systems’s latest quarter earnings to come in at $0.01 per share, but it turned out to be $0.05, a 400.00% surprise. For the quarter, EBITDA amounted to $0.55 million. Shareholders own equity worth $27.5 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Aehr Test Systems (AEHR) price momentum. RSI 9-day as of the close on 28 December was 28.17%, suggesting the stock is oversold, with historical volatility in this time frame at 51.75%.

As of today, AEHR’s price is $20.95 -11.56% or -$2.60 from its 5-day moving average. AEHR is currently trading -23.25% lower than its 20-day SMA and +33.29% higher than its 100-day SMA. However, the stock’s current price level is +18.45% above the SMA50 and +119.65% above the SMA200.

The stochastic %K and %D were 10.45% and 14.25%, respectively, and the average true range (ATR) was 1.72. With the 14-day stochastic at 5.01% and the average true range at 1.80, the RSI (14) stands at 36.61%. The stock has reached -1.46 on the 9-day MACD Oscillator while the 14-day reading was at -2.27.

Analyst Ratings

William Blair launched coverage on Aehr Test Systems (NASDAQ: AEHR) in its analyst report released on October 17, 2022. The firm assigned the stock an Outperform rating.


Please enter your comment!
Please enter your name here